Abiopharma

ICU MEDICAL INC/DE (ICUI)

Symbol	ICUI
Name	ICU MEDICAL INC/DE
Sector	HEALTH CARE
Region	North America
Industry	Surgical & Medical Instruments & Apparatus
Address	951 CALLE AMANECER, SAN CLEMENTE, CA 92763-6212
Telephone	949-366-2183
Fax	—
Email	—
Website	https://www.icumed.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0000883984
Description	ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICUs acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically. Additional info from NASDAQ: ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICUs acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically.

2026-05-15 16:19

Sanzone Virginia Ruth 🔴 sold 2.4K shares of ICU MEDICAL INC/DE (ICUI) at $124.08 Transaction Date: May 14, 2026 | Filing ID: 000003

2026-05-14 22:48

📋 VIRGINIA SANZONE (Officer) plans to sell 2K shares of ICU MEDICAL, INC. (at $124.08 each, total $304K) Filed: May 14, 2026 | ID: 004563

2026-05-14 01:29

Director KENNEDY KOLLEEN T 🟡 adjusted position in 1.5K shares (2 derivative) of ICU MEDICAL INC/DE (ICUI) Transaction Date: May 13, 2026 | Filing ID: 000001

2026-05-14 01:20

Director Hernandez Laurie 🟡 adjusted position in 1.5K shares (2 derivative) of ICU MEDICAL INC/DE (ICUI) Transaction Date: May 13, 2026 | Filing ID: 000001

2026-05-14 01:11

Director FINNEY ELISHA W 🟡 adjusted position in 1.5K shares (2 derivative) of ICU MEDICAL INC/DE (ICUI) Transaction Date: May 13, 2026 | Filing ID: 000001

2026-05-14 00:52

Director Abbey Donald 🟡 adjusted position in 1.5K shares (2 derivative) of ICU MEDICAL INC/DE (ICUI) Transaction Date: May 13, 2026 | Filing ID: 000008

2026-05-14 00:38

Director Hoffmeister David F 🟡 adjusted position in 1.5K shares (2 derivative) of ICU MEDICAL INC/DE (ICUI) Transaction Date: May 13, 2026 | Filing ID: 000004

2026-05-14 00:31

Director Greenberg David C. 🟡 adjusted position in 949 shares (3 derivative) of ICU MEDICAL INC/DE (ICUI) at $122.91 Transaction Date: May 13, 2026 | Filing ID: 000001

2026-05-13 17:35

New Form SCHEDULE 13G/A - ICU MEDICAL INC/DE Filed: 2026-05-13 AccNo: 0001941040-26-000337 Size: 7 KB

2026-05-12 21:39

📋 DAVID C GREENBERG (Director) plans to sell 2K shares of ICU MEDICAL, INC. (at $122.91 each, total $298K) Filed: May 12, 2026 | ID: 004424

No clinical trials found for this company.

No clinical products found for this company.